CRL PEER ANALYSIS

Charles River Laboratories — metric-by-metric comparison with peers and the industry median

CRLCharles River Laboratories

🇺🇸 USA · US · Healthcare · Diagnostics & Research

Value it Duel

Overall Profile & Returns

· Diagnostics & Research

Position Within Industry

0 = weak quartile, 100 = strong quartile

CRLIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	CRL	ERF	SHL	Ind. Median
P/E	—	26.40	20.03●	28.95
P/B	3.73	3.54	1.26●	3.39
EV/EBITDA	47.59	11.86	9.80●	20.39
P/S	2.72	1.72	1.04●	4.21

Financial Health
Metric	CRL	ERF	SHL	Ind. Median
Current Ratio	1.36●	1.09	1.01	1.87
Debt/Equity	103.9%	153.3%	85.8%●	49.3%
NetDebt/EBITDA	9.86	3.20●	3.78	1.92

Profitability
Metric	CRL	ERF	SHL	Ind. Median
Net Margin	-4.6%	6.5%●	5.2%	6.7%
ROE	-6.0%	10.7%●	6.4%	6.4%
ROA	-2.4%	4.3%●	3.3%	3.3%
EBITDA Margin	7.2%	19.9%●	17.3%	18.8%

Growth + Dividend
Metric	CRL	ERF	SHL	Ind. Median
Rev. Growth	0.1%	5.0%	11.4%●	9.1%
NI Growth	—	16.9%●	-1.1%	12.4%
Div. Yield	—	1.0%	5.2%●	0.8%
Payout	—	23.2%	96.9%	23.2%

Valuation
Metric	CRL	RVTY	QGEN	MEDP	TWST	GH	Ind. Median
P/E	—	50.77	19.74●	33.47	—	—	28.95
P/B	3.73	1.70	2.38	25.75	12.12	-113.22●	3.39
EV/EBITDA	47.59	19.05	11.49●	24.80	—	—	20.39
P/S	2.72●	4.21	3.78	5.75	13.47	18.98	4.21

Financial Health
Metric	CRL	RVTY	QGEN	MEDP	TWST	GH	Ind. Median
Current Ratio	1.36	1.72	3.21	0.85	2.70	4.68●	1.87
Debt/Equity	103.9%	46.6%	49.4%	20.4%	21.1%	-941.4%●	49.3%
NetDebt/EBITDA	9.86	3.22	1.29	-0.88	1.35	-1.54●	1.92

Profitability
Metric	CRL	RVTY	QGEN	MEDP	TWST	GH	Ind. Median
Net Margin	-4.6%	8.3%	19.2%●	17.2%	-19.8%	-40.1%	6.7%
ROE	-6.0%	3.3%	11.9%	77.3%●	-18.2%	—	6.4%
ROA	-2.4%	2.0%	7.1%	22.9%●	-12.8%	-26.6%	3.3%
EBITDA Margin	7.2%	26.6%	37.1%●	22.4%	-13.8%	-36.2%	18.8%

Growth + Dividend
Metric	CRL	RVTY	QGEN	MEDP	TWST	GH	Ind. Median
Rev. Growth	0.1%	4.8%	4.8%	24.2%	17.8%	39.6%●	9.1%
NI Growth	—	-22.4%	329.3%●	10.6%	—	—	12.4%
Div. Yield	—	0.3%	0.7%●	—	—	—	0.8%
Payout	—	13.4%	13.5%	—	—	—	23.2%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on CRL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.